CN104383251A - Koji capsule and preparation method thereof - Google Patents
Koji capsule and preparation method thereof Download PDFInfo
- Publication number
- CN104383251A CN104383251A CN201410703481.2A CN201410703481A CN104383251A CN 104383251 A CN104383251 A CN 104383251A CN 201410703481 A CN201410703481 A CN 201410703481A CN 104383251 A CN104383251 A CN 104383251A
- Authority
- CN
- China
- Prior art keywords
- radix
- carbon dioxide
- capsule
- heart
- ground
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000001035 drying Methods 0.000 claims abstract description 17
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 15
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- 239000006071 cream Substances 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 21
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 108010011485 Aspartame Proteins 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 8
- 229960003438 aspartame Drugs 0.000 claims description 8
- 235000010357 aspartame Nutrition 0.000 claims description 8
- 239000000605 aspartame Substances 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 238000005550 wet granulation Methods 0.000 claims description 7
- 206010002383 Angina Pectoris Diseases 0.000 claims description 6
- 208000000059 Dyspnea Diseases 0.000 claims description 5
- 206010013975 Dyspnoeas Diseases 0.000 claims description 5
- 206010040007 Sense of oppression Diseases 0.000 claims description 5
- 208000029078 coronary artery disease Diseases 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 230000035807 sensation Effects 0.000 claims description 5
- 208000013220 shortness of breath Diseases 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 7
- 240000000691 Houttuynia cordata Species 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 abstract 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000028419 Styrax benzoin Species 0.000 abstract 1
- 235000000126 Styrax benzoin Nutrition 0.000 abstract 1
- 235000008411 Sumatra benzointree Nutrition 0.000 abstract 1
- 229960002130 benzoin Drugs 0.000 abstract 1
- 235000019382 gum benzoic Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000008092 positive effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 3
- 241000657480 Crataegus pinnatifida Species 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 2
- 244000303323 Styrax tonkinensis Species 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241001060310 Styracaceae Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a koji capsule and a preparation method thereof. The preparation method of the koji capsule is characterized by taking 80g of houttuynia cordata, 27g of benzoin, 150g of pseudo-ginseng, 80g of ginseng, 80g of radix ophiopogonis, 120g of salviae miltiorrhizae and 230g of hawthorn, extracting by adopting a carbon dioxide supercritical extraction method, carrying out reduced pressure drying, smashing to nano dry paste by adopting a high-energy nano impact mill, adding a functional auxiliary material, and preparing the koji capsule. The preparation method of the koji capsule has the advantages that disintegration time is obviously shortened, curative effect is obvious better than that of commercially available koji capsules, and a positive effect is obtained.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Kang Er heart-soothing capsule and preparation method thereof.
Background technology
Kang Er heart-soothing capsule benefiting QI for activating blood circulation, enriching yin and nourishing kidney, increase coronary flow, blood fat reducing.Be used for the treatment of coronary heart disease, angina pectoris, the diseases such as sensation of oppression over the chest with shortness of breath.Commercially available Kang Er heart-soothing capsule is due to prescription and technological reason, and curative effect is not satisfactory, and preparation adopts traditional handicraft preparation, there is the deficiencies such as prolonged disintegration, curative effect are low.
Summary of the invention
The present invention, for overcoming above-mentioned deficiency, provides Kang Er heart-soothing capsule that a kind of disintegration rate is fast, curative effect is high and preparation method thereof.
Invention embodiment is as follows:
Get Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, is ground into 60 order coarse powder, adopts carbon dioxide supercritical extraction method to extract, extracting pressure 30 ~ 40Mpa, extraction temperature 30 ~ 40 DEG C, separator pressure 10 ~ 20Mpa, separator temperature 50 ~ 60 DEG C, disengaging time 2 ~ 4 hours, carbon dioxide flow 40 ~ 50L per hour, obtains extracting solution; Get extracting solution 60 DEG C ~ 80 DEG C drying under reduced pressure, get dry extract; Get dry cream and add aspartame 150 ~ 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 45 ~ 55g, crospolyvinylpyrrolidone 45 ~ 55g, cross-linking sodium carboxymethyl cellulose 35 ~ 45g, mix homogeneously, with 50 ~ 70% ethanol wet granulations, 60 DEG C ~ 80 DEG C dryings, additional carboxymethyl starch sodium 7 ~ 9g, magnesium stearate 1 ~ 3g, granulate, incapsulates, obtained Kang Er heart-soothing capsule 1000.
The raw material standards that above-mentioned embodiment is mentioned is as follows:
Herba Houttuyniae: China's coastal port one ministerial standard.This product is the fresh herb of saururaceae plant houttuynia cordata Houttuynia cordata Thunb. or dry aerial parts, fresh goods all can be tapped the whole year; Tap when the luxuriant spica of dry product stem and leaf in summer is many, removing impurity, dries.
Benzoinum: China's coastal port one ministerial standard.This product is Styracaceae plant styrax tonkinensis Craib ex Hart Styrax tonkinensis(Pierre) dry resin of Craib ex Hart..Trunk, through naturally damaging or isolating trunk in summer, Qiu Erji, is collected the resin flowed out, is dried in the shade.
Radix Notoginseng: China's coastal port one ministerial standard.This product is the dry root and rhizome of panax araliaceae plant Punax notoginseng (Burk.) F.H.Chen.Autumn excavates before the flowers are in blossom, cleans, and separately main root, a root and rhizome, dry.Supporting root is practised and is claimed " rib ", and rhizome is practised and claimed " clip ".
Radix Ginseng: China's coastal port one ministerial standard.This product is the dry root and rhizome of Araliaceae Radix Ginseng Panax ginseng C.A.Mey..Excavate more than autumn, clean through drying or drying.Cultivation also known as " Park Ginseng "; Sowing under mountain forest wild state self-sow also known as " Panax Ginseng ", practise and claim " seed sea ".
Radix Ophiopogonis: China's coastal port one ministerial standard.This product is liliaceous plant Ophiopogon Radix Ophiopogonis japonicus(Thunb.) dried root of Ker-Gawl..Summer excavates, and cleans, is repeatedly exposed to the sun, banks up. and to very likely in, removing fibrous root, dry.
Radix Salviae Miltiorrhizae: China's coastal port one ministerial standard.This product is the dry root and rhizome of labiate Radix Salviae Miltiorrhizae Salvia miltiorrhiza Bge..Spring, Qiu Erji excavate, removing silt, dry.
Fructus Crataegi: China's coastal port one ministerial standard.This product is the dry mature fruit of rosaceous plant Fructus Pyri Pashiae Crataegus Pinnatifida Bge. var.major. N.E.Br. or crataegus pin natifida var. Major Crataegus pinnatifida Bge..Gather during fruit maturation in autumn.Section, dry.
Aspartame: Chinese Pharmacopoeia version two ministerial standard in 2010.
Microcrystalline Cellulose: Chinese Pharmacopoeia version two ministerial standard in 2010.
Crospolyvinylpyrrolidone: Chinese Pharmacopoeia version two ministerial standard in 2010.
Cross-linking sodium carboxymethyl cellulose: Chinese Pharmacopoeia version two ministerial standard in 2010.
Carboxymethyl starch sodium: Chinese Pharmacopoeia version two ministerial standard in 2010.
Magnesium stearate: Chinese Pharmacopoeia version two ministerial standard in 2010.
Raw material used by above Kang Er heart-soothing capsule all can be bought from pharmaceuticals and obtain, and all can be used to implement the present invention program as long as meet national standard.
In foregoing invention scheme, term used is pharmacy proprietary term, as " decompression " etc. all defers to Chinese Pharmacopoeia regulation and pharmaceutical practice of being correlated with.
Unit g in the present invention also can be other weight portion, does not affect the enforcement of the present invention program.
Equipment Market described in the present invention program all has sale, is not limited to typical production producer, as long as technical specification can reach requirement, all can be used to realize the present invention.
Four detailed description of the invention
Specific embodiments of the invention 1
Get Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, is ground into 60 order coarse powder, adopts carbon dioxide supercritical extraction method to extract, extracting pressure 30Mpa, extraction temperature 30 DEG C, separator pressure 10Mpa, separator temperature 50 DEG C, disengaging time 2 hours, carbon dioxide flow 40L per hour, obtains extracting solution; Get extracting solution 60 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add aspartame 150g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 45g, crospolyvinylpyrrolidone 45g, cross-linking sodium carboxymethyl cellulose 35g, mix homogeneously, with 50% ethanol wet granulation, 60 DEG C of dryings, additional carboxymethyl starch sodium 7g, magnesium stearate 1g, granulate, incapsulates, obtained Kang Er heart-soothing capsule 1000.
Specific embodiments of the invention 2
Get Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, is ground into 60 order coarse powder, adopts carbon dioxide supercritical extraction method to extract, extracting pressure 40Mpa, extraction temperature 40 DEG C, separator pressure 20Mpa, separator temperature 60 DEG C, disengaging time 4 hours, carbon dioxide flow 50L per hour, obtains extracting solution; Get extracting solution 80 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add aspartame 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 55g, crospolyvinylpyrrolidone 55g, cross-linking sodium carboxymethyl cellulose 45g, mix homogeneously, with 70% ethanol wet granulation, 80 DEG C of dryings, additional carboxymethyl starch sodium 9g, magnesium stearate 3g, granulate, incapsulates, obtained Kang Er heart-soothing capsule 1000.
Specific embodiments of the invention 3
Get Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, is ground into 60 order coarse powder, adopts carbon dioxide supercritical extraction method to extract, extracting pressure 35Mpa, extraction temperature 35 DEG C, separator pressure 15Mpa, separator temperature 55 DEG C, disengaging time 3 hours, carbon dioxide flow 45L per hour, obtains extracting solution; Get extracting solution 70 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add aspartame 175g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 50g, crospolyvinylpyrrolidone 50g, cross-linking sodium carboxymethyl cellulose 40g, mix homogeneously, with 60% ethanol wet granulation, 70 DEG C of dryings, additional carboxymethyl starch sodium 8g, magnesium stearate 2g, granulate, incapsulates, obtained Kang Er heart-soothing capsule 1000.
Above embodiment illustrates, adopts the extreme condition of embodiment of the present invention and optimal conditions all can make Kang Er heart-soothing capsule.Actual effect of the present invention is investigated below with the Kang Er heart-soothing capsule that embodiment 3 is obtained:
(1) embodiment 3 Kang Er heart-soothing capsule and contrast disintegration of commercially available Kang Er heart-soothing capsule
1 disintegration time mensuration method
Measure by Chinese Pharmacopoeia version annex Ⅻ A in 2010.
Contrast 2 disintegrations
Table 1 embodiment 3 Kang Er heart-soothing capsule and commercially available Kang Er heart-soothing capsule contrast table disintegration
The above results shows, Kang Er heart-soothing capsule prepared by the present invention has the remarkable advantages such as disintegration rate is fast, bioavailability is high relative to commercially available Kang Er heart-soothing capsule.
(2) embodiment 3 Kang Er heart-soothing capsule and commercially available Kang Er heart-soothing capsule treatment coronary heart disease, angina pectoris, sensation of oppression over the chest with shortness of breath Disease Clinical observation of curative effect
1 case scenario
Statistics outpatient service and inpatient, observe coronary heart disease, angina pectoris altogether, sensation of oppression over the chest with shortness of breath disease case 138 example, 59 years old mean age.Patient is divided into two groups, test group takes embodiment 3 Kang Er heart-soothing capsule, and matched group takes commercially available Kang Er heart-soothing capsule.
2 efficacy assessment standards
According to new Chinese medicine treatment angina pectoris guideline of clinical investigations tcm syndrome curative effect determinate standard:
Effective: tcm clinical practice symptom, sign are obviously improved, syndrome integral reduces >=70%.
Effective: tcm clinical practice symptom, sign all take a favorable turn, syndrome integral reduces >=30%.
Invalid: tcm clinical practice symptom, sign are all not improved or increase the weight of, syndrome integral reduces < 30%.
Increase the weight of: tcm clinical practice symptom, sign all have and increase the weight of, syndrome integral reduces < 0.
Computing formula: [before (before treatment the rear integration of integration-treatment) ÷ treatment integration] × 100%.
3 clinical observation result
Table 2 embodiment 3 Kang Er heart-soothing capsule and commercially available Kang Er heart-soothing capsule clinical efficacy contrast table
Above-mentioned clinical observation on the therapeutic effect result shows, Kang Er heart-soothing capsule prepared by the present invention is treating coronary heart disease, angina pectoris, during sensation of oppression over the chest with shortness of breath disease, evident in efficacy higher than commercially available Kang Er heart-soothing capsule, p < 0.05.
Claims (3)
1. treat a coronary heart disease, angina pectoris, the Chinese medicine of sensation of oppression over the chest with shortness of breath, is characterized in that getting Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, be ground into 60 order coarse powder, adopt carbon dioxide supercritical extraction method to extract, extracting pressure 30 ~ 40Mpa, extraction temperature 30 ~ 40 DEG C, separator pressure 10 ~ 20Mpa, separator temperature 50 ~ 60 DEG C, disengaging time 2 ~ 4 hours, carbon dioxide flow 40 ~ 50L per hour, obtains extracting solution; Get extracting solution 60 DEG C ~ 80 DEG C drying under reduced pressure, get dry extract; Get dry cream and add aspartame 150 ~ 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 45 ~ 55g, crospolyvinylpyrrolidone 45 ~ 55g, cross-linking sodium carboxymethyl cellulose 35 ~ 45g, mix homogeneously, with 50 ~ 70% ethanol wet granulations, 60 DEG C ~ 80 DEG C dryings, additional carboxymethyl starch sodium 7 ~ 9g, magnesium stearate 1 ~ 3g, granulate, incapsulates, obtained Kang Er heart-soothing capsule.
2. the preparation method of Chinese medicine according to claim 1, is characterized in that getting Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, be ground into 60 order coarse powder, employing carbon dioxide supercritical extraction method is extracted, extracting pressure 30 ~ 40Mpa, extraction temperature 30 ~ 40 DEG C, separator pressure 10 ~ 20Mpa, separator temperature 50 ~ 60 DEG C, disengaging time 2 ~ 4 hours, carbon dioxide flow 40 ~ 50L per hour, obtains extracting solution; Get extracting solution 60 DEG C ~ 80 DEG C drying under reduced pressure, get dry extract; Get dry cream and add aspartame 150 ~ 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 45 ~ 55g, crospolyvinylpyrrolidone 45 ~ 55g, cross-linking sodium carboxymethyl cellulose 35 ~ 45g, mix homogeneously, with 50 ~ 70% ethanol wet granulations, 60 DEG C ~ 80 DEG C dryings, additional carboxymethyl starch sodium 7 ~ 9g, magnesium stearate 1 ~ 3g, granulate, incapsulates, obtained Kang Er heart-soothing capsule.
3. the preparation method of Chinese medicine according to claim 1, gets Herba Houttuyniae 80g, Benzoinum 27g, Radix Notoginseng 150g, Radix Ginseng 80g, Radix Ophiopogonis 80g, Radix Salviae Miltiorrhizae 120g, Fructus Crataegi 230g, be ground into 60 order coarse powder, employing carbon dioxide supercritical extraction method is extracted, extracting pressure 35Mpa, extraction temperature 35 DEG C, separator pressure 15Mpa, separator temperature 55 DEG C, disengaging time 3 hours, carbon dioxide flow 45L per hour, obtains extracting solution; Get extracting solution 70 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add aspartame 175g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 50g, crospolyvinylpyrrolidone 50g, cross-linking sodium carboxymethyl cellulose 40g, mix homogeneously, with 60% ethanol wet granulation, 70 DEG C of dryings, additional carboxymethyl starch sodium 8g, magnesium stearate 2g, granulate, incapsulates, obtained Kang Er heart-soothing capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410703481.2A CN104383251A (en) | 2014-11-30 | 2014-11-30 | Koji capsule and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410703481.2A CN104383251A (en) | 2014-11-30 | 2014-11-30 | Koji capsule and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104383251A true CN104383251A (en) | 2015-03-04 |
Family
ID=52601275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410703481.2A Withdrawn CN104383251A (en) | 2014-11-30 | 2014-11-30 | Koji capsule and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104383251A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311281A (en) * | 2015-11-20 | 2016-02-10 | 王立鑫 | Health maintenance honeyed bolus for relieving dyspnea chest discomfort |
-
2014
- 2014-11-30 CN CN201410703481.2A patent/CN104383251A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311281A (en) * | 2015-11-20 | 2016-02-10 | 王立鑫 | Health maintenance honeyed bolus for relieving dyspnea chest discomfort |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104383251A (en) | Koji capsule and preparation method thereof | |
| CN105381402A (en) | Qi-regulating and heart-soothing tablet and preparation method thereof | |
| CN105708938A (en) | Haemorrhoid tablet and preparation method thereof | |
| CN104383254A (en) | Tianwang heart-invigorating pill and preparation method thereof | |
| CN105456763A (en) | Shenkangning capsules and preparation method thereof | |
| CN104224945A (en) | Hepatitis B body-resistance-strengthening capsule and preparation method thereof | |
| CN105412028A (en) | Lipid-lowering tablet and preparation method thereof | |
| CN104398951A (en) | Stomachache tablet and preparation method thereof | |
| CN105456700A (en) | Kidney-tonifying bone-supplementing capsule and preparation method thereof | |
| CN105343681A (en) | Cough-relieving exocarpium citri grandis capsules and preparation method thereof | |
| CN105343375A (en) | Guanmaikang capsules and preparing method thereof | |
| CN105343336A (en) | Xiaotangling capsules and preparing method thereof | |
| CN104474384A (en) | Fuganning tablet and preparation method thereof | |
| CN105343677A (en) | Embolism eliminating and collateral dredging capsules and preparing method thereof | |
| CN105727065A (en) | Naoluotong capsule and preparation method thereof | |
| CN105343574A (en) | Coronal relaxing capsule and preparation method thereof | |
| CN104474167A (en) | Jiuerxin capsules and preparation method thereof | |
| CN105412598A (en) | Stomach-recovering capsule and preparation method thereof | |
| CN105708956A (en) | Fu Youning tablet and preparation method thereof | |
| CN104398571A (en) | Red sage root heart-soothing capsule and preparation method thereof | |
| CN105343730A (en) | Capsule for treating ulcers and preparation method thereof | |
| CN105770584A (en) | Heart calming tablet and preparation method thereof | |
| CN105343509A (en) | Yuquan capsules and preparation method thereof | |
| CN105412457A (en) | Capsule for treating hemialgia and preparation method thereof | |
| CN105362344A (en) | Hongyao tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150304 |
|
| WW01 | Invention patent application withdrawn after publication |